We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Exhibits Full Range of Molecular Diagnostic Solutions

By LabMedica International staff writers
Posted on 14 Nov 2023
Print article
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)
Image: Randox is exhibiting its extensive range of products and services at Hall 3 Stand A08 at MEDICA 2023 (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is exhibiting its full range of molecular diagnostic solutions at MEDICA 2023. Designed to meet the demands of today’s molecular diagnostic laboratory, the Randox range of molecular products comprises IQC and EQA for molecular infectious disease testing as well as point of care, semi and fully automated analyzers.

As a provider of high-quality diagnostic solutions, Randox offers a wide range of products and services, including quality control, molecular diagnostics, third-party reagents, point of care, and clinical chemistry analyzers. At MEDICA 2023, Randox is demonstrating the Vivalytic all-in-one molecular solution that consolidates full molecular workflow into one small benchtop platform. Randox’s multiplex Biochip Technology powers the Vivalytic, enabling multiple results from one patient sample. Randox is also highlighting the new Acusera true third-party controls alongside the ACUSERA 24•7 Interlaboratory Data Management for external quality assessment with features such as; interactive Levey-Jennings charts, automatic calculation for uncertainty of measurement as well as the comprehensive reports generated on demand.

In addition, Randox is showcasing the RX misano high-performance semi-automated clinical chemistry analyzer that is capable of high-standard, precise results at a competitive price per test. It can expand testing capabilities with the ability to run both routine and specialized tests including chemistries, specific proteins, antioxidants, veterinary and diabetes testing, and analyzing a variety of sample types, including serum, plasma, and urine. Randox is also highlighting the RX monaco fully automated clinical chemistry analyzer that comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes, and veterinary testing with emergency and STAT sampling. The RX monaco is ideal for low to mid-volume clinical chemistry testing consolidating routine and specialized testing onto one efficient and easy-to-use platform.

Related Links:
Randox Laboratories 

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Celiac Disease Test
AESKULISA tTg-A New Generation
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.